Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irbesartan/HCTZ Combination as First-Line Treatment for Moderate Hypertension
2004-000033-11Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of irbesartan in hypertension (HTN) (3 arms), sponsored by Bristol Myers Squibb. Primary endpoint: Change in seated systolic blood pressure at Week 8. Started Oct 2004; status: completed.
02
Drugs
irbesartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2004-000033-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000033-11.